Fig. 3From: Molecular imaging biomarkers for cell-based immunotherapiesLATEST from lymphoma tumors [42]. a–c Anatomical image from three animals, with flank tumor region indicated by dotted red line, and the LATEST maps (d–f) pre-infusion and (g–i) post-infusion with (j) corresponding asymmetry plots (asymmetry from Animal 3 in the third row is taken from region indicated in dotted black line), (k) LATEST change at 0.4 ppm from three animals pre- and post-infusion, (l) representative SEL-MQC1H-MRS pre- and 40 min post-infusion from flank tumor showing (m) increase in lactate peak amplitude from three animals (~40%) from spectroscopy. Reproduced with permissionBack to article page